UNC Lineberger Comprehensive Cancer Center

UNC Lineberger Comprehensive Cancer Center UNC Lineberger Comprehensive Cancer Center is the only public NCI-designated comprehensive cancer center. Serving patients at the N.C.

The UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. Basnight Cancer Hospital, UNC Lineberger is the only public comprehensive cancer center in the state of North Carolina. One of the leading cancer centers in the nation, UNC Lineberger Comprehensive Cancer Center is located in Chapel Hill, North Carolina. As o

ne of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, UNC Lineberger was rated as exceptional – the highest category – by the National Cancer Institute. The center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer. UNC Lineberger Comprehensive Cancer Center's Facebook comments guidelines:

Thank you for liking the page of the UNC Lineberger Comprehensive Cancer Center. This page highlights information about the people and programs at the cancer center and the North Carolina Basnight Cancer Hospital. Consistent with UNC-Chapel Hill’s Policy on Prohibited Discrimination, Harassment and Related Misconduct, and the North Carolina Campus Free Speech Act, we encourage your comments and opinions as they relate to our posts. This page is actively monitored for relevance. UNC Lineberger reserves the right to remove any comments that are not related to the particular post, make unsupported accusations, contain ad-hominem attacks, use obscene language or images, are blatant spam, contain advertisements, or contain inappropriate personal information or sensitive information. Repeated violation of these guidelines or behavior that substantially disrupts the maintenance of this page could result in a user being blocked from the page. Thanks for keeping the page enjoyable for everyone. This page will not:
- Infringe on the rights of any third-party, including intellectual property, privacy/confidentiality, or publicity rights
- Post content that is unlawful, obscene, defamatory, threatening, abusive, slanderous, or embarrassing to any other person or entity as determined by UNC Health or its affiliates in its sole discretion
- Post political or offensive content of any nature
- Impersonate another person
- Allow any other person or entity to use my identification for posting content
- Post the same content more than once or “spam”
- Post chain letters, pyramid schemes, advertisements or solicitations of business
- Post phone numbers or email addresses
- Post personal health information or other confidential information that is not my - own
- Post solicitations for fundraising efforts not sponsored by or benefiting UNC Health or involving an official UNC Health affiliate

The Carolina Cancer Nanotechnology Training Program (CCNTP) at the UNC Eshelman School of Pharmacy is now accepting appl...
09/02/2026

The Carolina Cancer Nanotechnology Training Program (CCNTP) at the UNC Eshelman School of Pharmacy is now accepting applications for its NIH/NCI-funded T32 Postdoctoral Training Program. The program prepares emerging scientists to advance cancer diagnosis and treatment through innovative nanotechnology research and interdisciplinary training.

Apply today: https://pharmacy.unc.edu/fellowship/ccntp-t32/

Jessica Thaxton, PhD, has been awarded a prestigious $700,000 grant from the Mathers Foundation to support research into...
08/31/2026

Jessica Thaxton, PhD, has been awarded a prestigious $700,000 grant from the Mathers Foundation to support research into the role of the endoplasmic reticulum in T-cell metabolism and cancer development.

Congratulations, Dr. Thaxton! 👏 Read the full story at the link in our comments.

08/28/2026

Earlier this week, the FDA approved a groundbreaking pancreatic cancer drug, daraxonrasib.

UNC Lineberger's Channing Der, PhD, a leading expert in pancreatic cancer research and KRAS, shared his reactions to this “monumental moment for the treatment of pancreatic cancer" with the American Cancer Society and NBC News.

“Pancreatic cancer is the third leading cause of cancer death in the U.S. and the deadliest of all cancers,” Der wrote in an email. “This is just the beginning of more advances to come.”

Click the 🔗 in our comments to the full NBC News article.

UNC Lineberger and OHSU receive $4 Million to address barriers to cancer screening across North Carolina and Oregon 🙌Led...
08/27/2026

UNC Lineberger and OHSU receive $4 Million to address barriers to cancer screening across North Carolina and Oregon 🙌

Led by Alison Brenner, PhD, MPH, and Stephanie Wheeler, PhD, MPH, researchers will develop and implement new strategies to address common barriers to care and reach patients due for screenings for breast, colorectal, lung, and cervical cancers.

Click the 🔗 in the comments to read the full story.

ICYMI: The UNC Get Real and Heel exercise program became a central part of recovery for Jennifer Fusco when she was diag...
08/26/2026

ICYMI: The UNC Get Real and Heel exercise program became a central part of recovery for Jennifer Fusco when she was diagnosed with ovarian cancer.

"They helped me every step of the way," Fusco said. "They've helped me build back my strength which has given me so much hope." 🩵

Full story and video at the 🔗 in our comments.

Awesome research from Kay Chung, PhD, that could lead to improved versions of therapies that use a patient's own immune ...
08/25/2026

Awesome research from Kay Chung, PhD, that could lead to improved versions of therapies that use a patient's own immune cells to fight cancer!

"We can build therapies that stay active longer and give patients a better chance at lasting cancer control," Chung said.

ICYMI: UNC researchers are recruiting North Carolinians between 45 and 75 years old who have not had a cancer diagnosis ...
08/24/2026

ICYMI: UNC researchers are recruiting North Carolinians between 45 and 75 years old who have not had a cancer diagnosis within the past five years for a study to see whether a blood test could detect 10 types of cancer.

Full story at the 🔗 in the comments.

Sign up today: https://unc.live/3SBKrmq

What's the role of clinical trials in cancer treatments? “Clinical trials are the only way to develop new cancer medicat...
08/21/2026

What's the role of clinical trials in cancer treatments?

“Clinical trials are the only way to develop new cancer medications, which will help patients live longer, have a higher likelihood of cure and have the least negative effects on quality of life,” says UNC Lineberger's Carrie Lee, MD, MPH.

Read more, including some common misconceptions of clinical trials, at the 🔗 in our comments.

Pengda Liu, PhD, and colleagues are investigating a new way to tackle Ewing sarcoma, an aggressive and rare pediatric ca...
08/21/2026

Pengda Liu, PhD, and colleagues are investigating a new way to tackle Ewing sarcoma, an aggressive and rare pediatric cancer that develops in the bones and soft tissues, while minimizing toxicity typically associated with chemotherapy.

Check out the full story at the 🔗 in our comments.

Address

450 West Drive
Chapel Hill, NC
27514

Telephone

+19199665905

Website

Alerts

Be the first to know and let us send you an email when UNC Lineberger Comprehensive Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category